CIK 0001604821 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 2.3 B | 820.2 M | ||
| Net income (USD) | -229.7 M | -124.8 M | ||
| Diluted EPS (USD/shares) | -1.52 | -5.57 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-15 | 144 | 144 | |
| 2026-10-09 | 4 | 4 | 2026-10-07 |
| 2026-10-02 | 4 | 4 | 2026-10-01 |
| 2026-10-02 | 4 | 4 | 2026-10-01 |
| 2026-10-01 | 144 | 144 | |
| 2026-10-01 | 144 | 144 | |
| 2026-09-25 | 4 | 4 | 2026-09-23 |
| 2026-09-23 | 144 | 144 | |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-17 | 4 | 4 | 2026-09-15 |
| 2026-09-16 | 4 | 4 | 2026-09-14 |
| 2026-09-15 | 144 | 144 | |
| 2026-09-11 | 4 | 4 | 2026-09-11 |
| 2026-09-11 | 144 | 144 | |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-02 | 144 | 144 | |
| 2026-09-01 | 144 | 144 | |
| 2026-09-01 | 144 | 144 | |
| 2026-08-28 | 4 | 4 | 2026-08-06 |
| 2026-08-14 | 4 | 4 | 2026-08-10 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-07 | 4 | 4 | 2026-08-07 |
| 2026-08-07 | 4 | 4 | 2026-08-07 |
Forms on file (last 1,000): 4 667, 144 207, 8-K 41, 10-Q 14, SC 13G/A 11, SCHEDULE 13G/A 8, S-8 8, 4/A 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=NTRA (0.002 USD), /gw/filings/filings?ticker=NTRA&form=8-K, /gw/filings/facts?ticker=NTRA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange